Technology Offerings

Innovative Ansamitocin Analogues Show Promise for Tumor Therapy

The invention comprises designed novel biologically highly potent ansamitocin analogues for tumor therapy, inlcuding among other new 19-deschloro and demethoxy derivatives of known AP-3 ansamitocin, showing a strong inhibitory effect on cell growth. They could be the basis for a cancer therapy, and might show fewer side effects than the known ones tested at clinical studies.

Further Information: PDF

MBM ScienceBridge GmbH
Phone: (0551) 30724-152

Contact
Dr. Jens-Peter Horst

Comments (0)

Write a comment